Metagenomi Inc. Common St...
(MGX)
undefined
undefined%
At close: undefined
3.32
0.15%
After-hours Dec 13, 2024, 07:52 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 |
Net Income | -68.25M | -43.59M | -21.44M |
Depreciation & Amortization | 4.21M | 1.73M | 387.00K |
Stock-Based Compensation | 6.92M | 1.96M | 375.00K |
Other Working Capital | -23.89M | 65.66M | 44.23M |
Other Non-Cash Items | -7.85M | 1.08M | 1.24M |
Deferred Income Tax | - | - | - |
Change in Working Capital | -26.43M | 69.49M | 46.26M |
Operating Cash Flow | -91.41M | 29.72M | 24.26M |
Capital Expenditures | -9.81M | -13.98M | -2.90M |
Acquisitions | - | - | - |
Purchase of Investments | -208.10M | -214.85M | -71.41M |
Sales Maturities Of Investments | 263.64M | 106.63M | - |
Other Investing Acitivies | - | -108.22M | -71.41M |
Investing Cash Flow | 45.73M | -122.20M | -74.32M |
Debt Repayment | - | - | 29.97M |
Common Stock Repurchased | - | - | - |
Dividend Paid | - | - | - |
Other Financial Acitivies | 1.01M | 239.59M | 9.95M |
Financial Cash Flow | 1.01M | 239.59M | 39.92M |
Net Cash Flow | -44.66M | 147.12M | -10.14M |
Free Cash Flow | -101.22M | 15.75M | 21.35M |